These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28620756)

  • 1. Preliminary data on utility of subcutaneous unfractionated heparin in patients with deep cerebral venous thrombosis.
    Kulkarni GB; Mirza AM; Ramakrishnan S; Mustare V
    J Thromb Thrombolysis; 2017 Aug; 44(2):247-253. PubMed ID: 28620756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.
    Coutinho JM; Ferro JM; Canhão P; Barinagarrementeria F; Bousser MG; Stam J;
    Stroke; 2010 Nov; 41(11):2575-80. PubMed ID: 20930161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinico-radiological study of deep cerebral venous thrombosis.
    Kalita J; Sachan A; Dubey AK; Jain N; Kumar S
    Neuroradiology; 2022 Oct; 64(10):1951-1960. PubMed ID: 35462575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
    Viegas LD; Stolz E; Canhão P; Ferro JM
    Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis.
    Ji K; Wu L; Zhao W; Wu C; Xu Y; Duan J; Meng R; Yan F; Chen J; Wu D; Luo Y; Ji X
    Aging (Albany NY); 2020 Jun; 12(12):11835-11842. PubMed ID: 32554865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort.
    Sidhom Y; Mansour M; Messelmani M; Derbali H; Fekih-Mrissa N; Zaouali J; Mrissa R
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1291-5. PubMed ID: 24462460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial venous hemodynamics is a factor related to a favorable outcome in cerebral venous thrombosis.
    Stolz E; Gerriets T; Bödeker RH; Hügens-Penzel M; Kaps M
    Stroke; 2002 Jun; 33(6):1645-50. PubMed ID: 12053005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
    Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
    Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DC-CRP: Deep Cerebral Venous Thrombosis, Clinicoradiological Profile, and Treatment Outcome in Indian Population-A Tertiary Care Experience.
    Goyal S; Murumkar V; Kulanthaivelu K; Agrawal NK; Mondal MS; Priyadarshini P; Dhar D; Kenchaiah R; Siani J
    J Assoc Physicians India; 2024 Oct; 72(10):38-44. PubMed ID: 39390857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of anticoagulation status on recanalization and outcome of cerebral venous thrombosis.
    Dubey AK; Kalita J; Chaudhary SK; Misra UK
    J Clin Neurosci; 2021 Jul; 89():43-50. PubMed ID: 34119293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of fixed-dose enoxaparin and adjusted-dose unfractionated heparin in patients with cerebral venous thrombosis.
    Korathanakhun P; Petpichetchian C; Petpichetchian W; Sathirapanya P
    Clin Neurol Neurosurg; 2017 Aug; 159():50-54. PubMed ID: 28535419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it safe to treat cerebral venous thrombosis with oral rivaroxaban without heparin? A preliminary study from 20 patients.
    Shankar Iyer R; Tcr R; Akhtar S; Muthukalathi K; Kumar P; Muthukumar K
    Clin Neurol Neurosurg; 2018 Dec; 175():108-111. PubMed ID: 30396036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, course and outcome in deep cerebral venous system thrombosis: an analysis of 32 cases.
    Pfefferkorn T; Crassard I; Linn J; Dichgans M; Boukobza M; Bousser MG
    J Neurol; 2009 Nov; 256(11):1839-45. PubMed ID: 19536581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial.
    Daskalopoulos ME; Daskalopoulou SS; Tzortzis E; Sfiridis P; Nikolaou A; Dimitroulis D; Kakissis I; Liapis CD
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):638-50. PubMed ID: 15878544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep cerebral vein thrombosis associated with iron deficiency anaemia in adults.
    Balci K; Utku U; Asil T; Büyükkoyuncu N
    J Clin Neurosci; 2007 Feb; 14(2):181-4. PubMed ID: 17161294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and  literature review.
    Alet M; Ciardi C; Alemán A; Bandeo L; Bonardo P; Cea C; Cirio J; Cossio J; Cuculic M; Esnaola MM; García-Pérez F; Giner F; Gómez-Schneider M; Isaac C; Lepera S; Martínez C; Martínez-Lorenzín R; Montes M; Orzuza G; Persi G; Povedano G; Pujol-Lereis V; Quiroga-Narváez J; Romano M; Sabio R; Viglione J; Zurrú MC; Saposnik G;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105145. PubMed ID: 32912503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recanalisation of cerebral venous thrombosis.
    Baumgartner RW; Studer A; Arnold M; Georgiadis D
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):459-61. PubMed ID: 12640063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review.
    Carrion AN; Allison TA; Samuel S
    J Thromb Thrombolysis; 2024 Apr; 57(4):691-698. PubMed ID: 38418744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.